InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
Posted
Vandana Singh (via Benzinga)
InMed Pharmaceuticals advances INM-901 as an oral treatment for Alzheimer's. Preclinical studies show the small molecule drug achieves effective brain levels, offering a promising alternative to traditional delivery methods.
read more
Biotech,
Briefs,
INM,
News,
Penny Stocks,
Stories That Matter,
why it's moving,
Health Care,
Top Stories,
Movers,
Trading Ideas,
General,
INM,
News,
Biotech,
Penny Stocks,
Health Care,
Top Stories,
Movers,
Trading Ideas,
General,
Benzinga
